| 10851171 |
Method for the selection of antibodies against BCMA |
Minh Diem Vu, Klaus Strein, Ralf Hosse, Oliver Ast, Anne Freimoser-Grundschober +5 more |
2020-12-01 |
| 10822402 |
Humanized anti-tau(pS422) antibodies and methods of use |
Stefan Dengl, Thomas Emrich, Guy Georges, Ulrich Goepfert, Fiona Grueninger +9 more |
2020-11-03 |
| 10781258 |
Bispecific T cell activating antigen binding molecules |
Marina BACAC, Thomas Hofer, Ralf Hosse, Christiane Neumann, Christian Klein +2 more |
2020-09-22 |
| 10781257 |
Bispecific T cell activating antigen binding molecules |
Marina BACAC, Thomas Hofer, Ralf Hosse, Christiane Neumann, Christian Klein +2 more |
2020-09-22 |
| 10766967 |
Bispecific T cell activating antigen binding molecules |
Marina BACAC, Tanja Fauti, Sabine Imhof-Jung, Christian Klein, Stefan Klostermann +5 more |
2020-09-08 |
| 10745470 |
Modified anti-tenascin antibodies and methods of use |
Ralf Hosse, Pablo Umana |
2020-08-18 |
| 10683369 |
Monoclonal antibodies against BCMA |
Minh Diem Vu, Klaus Strein, Oliver Ast, Marina BACAC, Camille DELON +6 more |
2020-06-16 |
| 10683368 |
Fc-region variants with modified FcRn-binding and methods of use |
Tilman Schlothauer |
2020-06-16 |
| 10584178 |
Bispecific HER2 antibodies and methods of use |
Rebecca CROASDALE-WOOD, Lydia Jasmin Hanisch, Guy Georges, Thomas Hofer, Ralf Hosse +7 more |
2020-03-10 |
| 10577429 |
Anti-FAP antibodies and methods of use |
Marina BACAC, Anne Freimoser-Grundschober, Ralf Hosse, Christian Klein, Valeria G. Nicolini +1 more |
2020-03-03 |
| 10562949 |
Interleukin-2 fusion proteins and uses thereof |
Ralf Hosse, Christian Klein, Laurence B. Peterson, Pablo Umana, Linda Wicker |
2020-02-18 |
